ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above Fifty Day Moving Average – Here’s What Happened

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $83.76 and traded as high as $99.29. ProShares Ultra Nasdaq Biotechnology shares last traded at $98.28, with a volume of 27,298 shares changing hands.

ProShares Ultra Nasdaq Biotechnology Trading Up 4.4%

The firm has a market capitalization of $91.40 million, a P/E ratio of 20.68 and a beta of 1.24. The business has a 50-day moving average of $83.76 and a 200 day moving average of $82.92.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Franklin Resources Inc. purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the second quarter worth $32,000. Citadel Advisors LLC purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 3rd quarter worth about $307,000. Finally, Kaizen Financial Strategies bought a new position in ProShares Ultra Nasdaq Biotechnology during the fourth quarter valued at approximately $424,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.